Press Release: Dupixent® demonstrates potential to become first biologic to treat COPD by showing significant reduction in exacerbations in pivotal trial 

https://ift.tt/a0oMkTF

Dupixent® demonstrates potential to become first biologic to treat COPD by showing significant reduction in exacerbations in pivotal trial 



from Sanofi - Aventis Groupe https://ift.tt/FhjLEmq
via IFTTT

Post a Comment

0 Comments